A multi-national, prospective mixed methods study of the effectiveness of naloxone (including intranasal Nyxoid) administration by lay people in reversing opioid overdose (NalPORS)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/45745
• EU PAS number:
  EUPAS41225
• Study ID:
  45745
• Official title and acronym:
  A multi-national, prospective mixed methods study of the effectiveness of naloxone (including intranasal Nyxoid) administration by lay people in reversing opioid overdose (NalPORS)
• DARWIN EU® study:
  No
• Study countries:
  Denmark

  Sweden

  United Kingdom (Northern Ireland)
• Study status:
  Ongoing

Research institutions and networks

Institutions

King's College London

Study timelines

Date when funding contract was signed

Planned: 12/02/2019

Actual: 12/02/2019

Study start date

Planned: 19/05/2021

Actual: 08/06/2021

Date of final study report

Planned: 31/08/2024

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Mundipharma Research Limited

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)